313 related articles for article (PubMed ID: 34480040)
21. Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.
Wang YM; Fan W; Zhang K; Zhang L; Tan Z; Ma R
Br J Radiol; 2016 Jul; 89(1063):20151050. PubMed ID: 27143439
[TBL] [Abstract][Full Text] [Related]
22. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
23. A contrast-enhanced ultrasound study of benign and malignant breast tissue.
Barnard S; Leen E; Cooke T; Angerson W
S Afr Med J; 2008 May; 98(5):386-91. PubMed ID: 18637311
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
[TBL] [Abstract][Full Text] [Related]
25. Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time.
Quarato CMI; Feragalli B; Lacedonia D; Rea G; Scioscia G; Maiello E; Di Micco C; Borelli C; Mirijello A; Graziano P; Dimitri L; Villani R; Sperandeo M
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832153
[No Abstract] [Full Text] [Related]
26. High-performance sonographical multimodal imaging of non cystic thyroid lesions: Chances of the preoperative diagnostics in relation to histopathology.
Brandenstein M; Wiesinger I; Jung F; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2021; 79(1):27-38. PubMed ID: 34334387
[TBL] [Abstract][Full Text] [Related]
27. The kinetic quantitative characteristics of non-mass breast lesions with contrast-enhanced ultrasound: a prospective study.
Cai YY; Du YC; Zhao L; Hu WJ; Bai Y; Chen A; Du LF; Li F
Br J Radiol; 2023 Dec; 96(1152):20221002. PubMed ID: 37660395
[TBL] [Abstract][Full Text] [Related]
28. Application of Quantitative Parameters of Contrast-Enhanced Ultrasound in Common Benign and Malignant Lesions in Pediatric Livers: A Preliminary Study.
Han D; Wang T; Wang R; Chen J; Tang Y
Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998580
[TBL] [Abstract][Full Text] [Related]
29. Color-coded perfusion analysis of CEUS for pre-interventional diagnosis of microvascularisation in cases of vascular malformations.
Teusch VI; Wohlgemuth WA; Piehler AP; Jung EM
Clin Hemorheol Microcirc; 2014; 58(1):183-93. PubMed ID: 25227194
[TBL] [Abstract][Full Text] [Related]
30. Monitoring parotid gland tumors with a new perfusion software for contrast-enhanced ultrasound.
Klotz LV; Ingrisch M; Eichhorn ME; Niemoeller O; Siedek V; Gürkov R; Clevert DA
Clin Hemorheol Microcirc; 2014; 58(1):261-9. PubMed ID: 25339101
[TBL] [Abstract][Full Text] [Related]
31. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
32. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
Che SN; Li J; Xue M; Song Y; Zhao LY; Guo N; Tian Y; Xie LZ; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):872-877. PubMed ID: 34407594
[No Abstract] [Full Text] [Related]
33. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
[TBL] [Abstract][Full Text] [Related]
34. Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results.
Lee SC; Tchelepi H; Grant E; Desai B; Luo C; Groshen S; Hovanessian-Larsen L
J Ultrasound Med; 2019 Sep; 38(9):2259-2273. PubMed ID: 30597640
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules.
Li CY; Gong HY; Ling LJ; Du LW; Su T; Wang S; Wang J
J Biomed Res; 2018 Jun; 32(3):198-207. PubMed ID: 29921747
[TBL] [Abstract][Full Text] [Related]
36. Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions.
Zhang Y; Zhang B; Fan X; Mao D
Exp Ther Med; 2020 Sep; 20(3):2063-2069. PubMed ID: 32782518
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.
Wang X; Xu P; Wang Y; Grant EG
Acta Radiol; 2011 Apr; 52(3):248-55. PubMed ID: 21498359
[TBL] [Abstract][Full Text] [Related]
38. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
[TBL] [Abstract][Full Text] [Related]
39. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity.
Lehotska V; Rauova K; Vanovcanova L
Neoplasma; 2018; 65(1):124-131. PubMed ID: 29322796
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
